Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Brought to you by
Sr. Director, HCP Compliance Maritz Travel, A Maritz Global Events Company
PAT SCHAUMANN, CMP, CSEP, DMCP, HMCC
ETHICS, TRANSPARENCY AND
COMPLIANCE IN HEALTHCARE
DISCLAIMER
THIS PRESENTATION DOES NOT
CONSTITUTE LEGAL GUIDANCE. IT WAS
PREPARED AS A SERVICE TO OUR
PARTICIPANTS AND IS INTENDED TO BE AN
INSTRUCTIONAL SUMMARY.
WHY IS THIS SO HARD?
1. Laws
2. Internal company compliance
3. Corporate Integrity Agreement (CIA)
4. Industry Association – PhRMA, AdvaMed, EFPIA, etc.
5. US State Exceptions
6. Military Physician regulations
7. Government
8. Cross-border Compliance
MANY MASTERS
COMPLIANCE:
Certification or confirmation that the doer of the action or the medical
drug or device manufacturer/supplier meets the requirements of
accepted practices, legislation, prescribed rules and regulations,
specified standards or the terms of a contract.
TYPES OF OVERSIGHT/REGULATION
Transparency
Rules
Standards
Policies
Regulations
Law
Requirements
Compliance
PROMOTE TRANSPARENCY BY
PUBLISHING FINANCIAL RELATIONSHIPS
BETWEEN THE MEDICAL INDUSTRY AND
HCPS.
CATEGORIES
Education
Research
Charitable contributions
Royalty or license
Ownership or investment
interest
Compensation for serving as
speaker for an accredited or
certified continuing education
program
Grant
Venue rental fees (teaching
hospitals only)
1.Encourage transparency of reporting financial ties.
2.Prevent inappropriate influence on research, education, and
clinical decision-making.
3.Avoid conflicts of interest that can compromise clinical integrity
and patient care.
4.BETTER PATIENT CARE!
U.S. – Covered Recipients, and Applicable
Manufacturers
Connecticut and Minnesota, Nevada, Chicago,
New Jersey – stay tuned
Europe – Member Industries, HCPs, and HCOs
CONQUERING GLOBAL SOURCING
CONFUSED? TOP CHALLENGES OF PLANNING
MEDICAL MEETINGS
Short lead time
Making changes on-site by staff without approval
Suppliers lacking knowledge of industry
Constantly changing laws and regulations
Trained staff
Understanding of industry issues by procurement,
compliance department and compliance attorneys
Privacy
GUIDE YOUR “CLIENT”
Set reasonable expectations upfront.
Make sure you are doing everything
possible to ensure that they make the
right decisions regarding compliance
and transparency.
ASK THE RIGHT QUESTIONS
Examples of key compliance-related questions to start with:
Who is sponsoring or paying for the meeting?
Who are the attendees and where are they from?
Are there any compliant meeting caps that will impact the
budget/planning?
Are there other guidelines/laws/regulations/codes that may govern the
meeting?
What data is required for reporting?
– Individual or aggregate?
CMS’ OPEN PAYMENTS 2017 REPORTING RESULTS
Applicable manufactures and Group Purchasing
Organizations collectively reported $8.40 billion in payments in
2017.
This amount is comprised of 11.54 million total records
attributable to 628,214 physicians and 1,158 teaching
hospitals.
NEW CHANGES AFFECTING MEDICAL MEETING
MANAGEMENT
KEY CHALLENGES: PRIVACY (EU)
Disclosure Code Privacy
Code Breaches
Industry Reputation
Criminal Prosecution
Relationship with HCP
Legal Obligation
HOW WILL THIS NEW REGULATION AFFECT MEDICAL MEETINGS?
GDPR: GENERAL DATA PROTECTION REGULATION
WHAT DOES IT MEAN?
Adopted by the European nations in 2016 and
effective May 25, 2018, this regulation is the EU’s
attempt to provide better protection for EU citizens,
and to allow them more control over their personal
information.
The regulation affects any events that involve
collection of personal data from an EU citizen who
attends events anywhere in the world.
SEVEN KEY REQUIREMENTS
1.
Consent
2.
Breach Notification
3.
Access
4.
Right to be Forgotten
5.
Data Portability
6.
Privacy by Design
7.
Data Protection Officer
PERSONAL DATA
What is personal data? What is not personal data?
A name or address of clients,
prospective clients, suppliers,
participants, employees and
candidates for job
Credit card information
IP address
Participants’ food habits, allergies,
etc.
A video of an event with no
identifiable persons
A folder in intranet with only
financial information
A statistical data, under conditions
The information regarding a legal
person
WHAT DOES THIS
MEAN TO YOUR
COMPANY?
Global Impact
Refers to any organization dealing
with data relating to person
located in the European Union
WHAT CAN WE EXPECT?
California Consumer Privacy Act of 2018
– Like the GDPR, this new legislation spells out rights for protection of the privacy of California consumers.
– Mashed together in less than a week
– Goes into effect January 1, 2020
FACTS,
TRENDS
AND
CHANGES
HOW WILL EUROPE’SNEW MEDTECH CODE
AFFECT YOUR MEETINGS?
WHAT IS CHANGING?
Once upon a time, member companies of MedTech Europe
— which started as a partnership between the medical-
technology trade organization Eucomed and the European
Diagnostic Manufacturers Association (EDMA) in 2012 —
could directly sponsor specific health-care providers (HCPs) to
support their trip to a third-party organized event such as a
medical meeting. But the Code of Ethical Business Practice
will do away with that.
THE MEDTECH EUROPE CODE OF ETHICAL BUSINESS
PRACTICE – THE CHANGE
The change calls for the discontinuation of direct
sponsorship of HCP’s
Independent medical education has to be supported
exclusively by means of Educational Grants.
Such Educational Grants can be provided to
Healthcare Organizations (HCOs) or Professional
Congress Organizers (PCOs or third-party meeting
planning organizations).
WHAT IS ACCME’S GUIDANCE FOR CME PROVIDERS
RELATEDTO REVISED INDUSTRY CODES?
What is their position on standards for commercial support that have
been introduced by MedTech Europe, AdvaMed, and APACMed,
organizations that represent the device manufacturing industry.
Expectations
Alignment between the revised codes and ACCME requirements
The main changes brought by the new code are:
1. The phasing out of the direct sponsorship
2. New transparency for educational grants
3. A common chapter on general criteria for events
4. A chapter on demonstration products and samples
5. Agreed definitions
6. A common independent enforcement mechanism
WHAT?
HOW DOES THE DIRECT
SPONSORSHIP BAN AFFECT YOU?
Member companies will not be able to provide financial or in-kind support
directly to individual healthcare professionals to cover the costs of their
attendance at third-party organized educational events.
Third-party educational events are interpreted broadly as including activities
of any type planned, budgeted, managed and executed in whole (or in
part) by another entity (other than the member company) to fulfill
healthcare professional medical educational needs. In practice, this
includes all third-party organized educational conferences such as national,
regional or specialty medical association conferences, educational
conferences organized by hospitals, conferences organized by professional
conference organizers, by accredited continuing medical education
providers and by patient organizations.
WHAT IS THE APPLICABILITY TO NON-MEMBER
COMPANIES?
Non-member companies may implement
these Disclosure Guidelines provided they
are committed to ethical standards
equivalent to those enshrined in the Code.
Non-member companies may prove this
commitment by obtaining the MedTech
Europe Ethical Business logo.
Resources
MedTech Europe Code’s Procedural Framework
http://www.medtecheurope.org/node/576
Resource section
http://www.medtrecheurope.org/node/1073
Code Hotline
ACCME
OTHER COUNTRY, STATE, CITY CHANGES? New Jersey
Chicago
Nevada
Vermont, Massachusetts, Minnesota, Washington,
DC, West Virginia, California, Connecticut,
Louisiana
• Stay educated – HMCC,
CMP-HC, industry
conferences, webinars
• Train your team
• Know the best resources
for updates
HOW TO KEEP
CURRENT
TOOLS
– Open Payments User Guide
– My Compliance Wizard – www.mycw.info
– MedTech Europe
– EFPIA web site
– “Breaking the Code to Healthcare Compliance”, 4th Edition
– http://www.meetingcompliance.com
Explore Open Payments DataFIND YOUR DOCTORS’ PAYMENTS
https://openpaymentsdata.cms.gov
Facts, Trends and Changes The Economist Intelligence Unit has predicted that more than 70% of
pharmaceutical sales this year will be made in countries with transparency
regulations.
The FDA is beginning to issue rules on usage of social media by
manufacturers.
Thank You!Please complete the
session evaluation in
the mobile app by
selecting the
clipboard icon on
the red toolbar with
the session page.